Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Hypertrophic cardiomyopathy is a common complication of Friedreich's ataxia (FRDA). Histological sections reveal abnormal cardiomyocytes, muscle fiber necrosis, reactive inflammation, and increased endomysial connective tissue. Scattered muscle fibers display perinuclear collections of minute iron-positive granules that lie in rows between myofibrils. Frataxin deficiency in FRDA causes mitochondrial iron dysmetabolism. We studied total iron and the iron-related proteins ferritin, mitochondrial ferritin, divalent metal transporter 1 (DMT1), and ferroportin in FRDA hearts by biochemical and histological techniques. Total iron in the left ventricular wall of FRDA patients (30.7+/-19.3 mg/100 g dry weight) was not significantly higher than normal (31.3+/-24.1 mg/100 g dry weight). Similarly, cytosolic holoferritin levels in FRDA hearts (230+/-172 microg/g wet weight) were not significantly elevated above normal (148+/-86 microg/g wet weight). The iron-positive granules exhibited immunoreactivity for cytosolic ferritin, mitochondrial ferritin, and ferroportin. Electron microscopy showed enhanced electron density of mitochondrial deposits after treatment with bismuth subnitrate supporting ferritin accumulation. The inflammatory cells in the endomysium were reactive for CD68, cytosolic ferritin, and the DMT1 isoform(s) translated from messenger ribonucleic acids containing iron-responsive elements (DMT1+). Progressive cardiomyopathy in FRDA is the likely result of iron-catalyzed mitochondrial damage followed by muscle fiber necrosis and a chronic reactive myocarditis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“clinical symptoms include cardiac hypertrophy [1128] and (pre-)diabetes [1129], consistent with the general thesis described here that all are in part manifestations of iron dysregulation, and in which suitable chelation may be beneficial [1130,1131]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1128]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“Total protein was determined according to Bradford (21).”
MethodCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 1×
“This circulating liver-derived peptide hormone causes internalization and degradation of ferroportin (26,39).”
BackgroundCloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · cited 1×
“In theory, iron excess should cause a more rapid turnover of DMT1+ mRNA due to the presence of an IRE in the 3’-UTR (33).”
BackgroundFriedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 2×
“In the more recent cases examined in Albany, New York (‘A’ in Table I) and whenever stored frozen tissue of older cases was available, FRDA was confirmed by polymerase chain reaction with specific deoxyoligonucleotide primers (4,16), agarose gel electrophoresis, and sizing of deoxyribonucleic acid (DNA) fragments cont…”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071 · cited 1×
“In patients with relatively short expansions, frataxin deficiency is not complete, and the clinical course is more benign (5).”
BackgroundAconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991 · cited 1×
“In biopsy samples of FRDA heart, the activities of ISC-requiring complexes I, II, and III of the electron transport chain, and of aconitase, are impaired (7).”
BackgroundTransferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 531 · cited 4×
“In macrophages, however, control of DMT1+ biosynthesis may be subject to cytokines such as c-interferon and tumor necrosis factor-a, and iron does not influence DMT1+ -mRNA translation in a mechanism like the tight control of TfR1.”
BackgroundInfluentialFilla, A., Michele, G. D., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G., & Cocozza, S. (1996) · PubMed · Cited by 496
Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479 · cited 3×
“To enhance the specificity of ferritin and ferroportin immunocytochemistry, the respective antisera were also used after pre-incubation with a 20-fold excess (by protein or polypeptide weight) of the respective antigens, human liver holoferritin (Calbiochem) and ferroportin-related peptide (26).”
BackgroundMethodSelf-citationBuja, L. M., & Roberts, W. C. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90240-3 · Cited by 472
A human mitochondrial ferritin encoded by an intronless gene
Levi, S., Corsi, B., Bosisio, M., Invernizzi, R., Volz, A., Sanford, D., Arosio, P., & Drysdale, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100141200 · Cited by 400 · cited 6×
“The presence of mitochondrial ferritin (12) in perinuclear granules supports their derivation from mitochondria (Fig.”
BackgroundInfluentialDMT1: A mammalian transporter for multiple metals
Garrick, M. D., Dolan, K. G., Horbinski, C., Ghio, A. J., Higgins, D., Porubcin, M., Moore, E. G., Hainsworth, L. N., Umbreit, J. N., Conrad, M. E., et al. (2003) · Biometals · doi:10.1023/a:1020702213099 · Cited by 377
Self-citationFrataxin-mediated Iron Delivery to Ferrochelatase in the Final Step of Heme Biosynthesis
Yoon, T., & Cowan, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400107200 · Cited by 282 · cited 1×
“Frataxin may also deliver iron to ferrochelatase (8).”
BackgroundIdebenone and reduced cardiac hypertrophy in Friedreich's ataxia
Hausse, A. O., Aggoun, Y., Bonnet, D., Sidi, D., Munnich, A., Rötig, A., & Rustin, P. (2002) · Heart · doi:10.1136/heart.87.4.346 · Cited by 252 · cited 1×
“If chelators are to be used, they must be able to enter the mitochondrial interior (48), and the combined administration of a chelating drug, an anti-inflammatory medication, and idebenone (49) may be beneficial.”
BackgroundIron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages
Knutson, M. D., Vafa, M. R., Haile, D. J., & Wessling-Resnick, M. (2003) · Blood · doi:10.1182/blood-2003-04-1250 · Cited by 227
Self-citationFriedreich ataxia: the oxidative stress paradox
Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.-C., Koenig, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi042 · Cited by 219
Iron Imports. II. Iron uptake at the apical membrane in the intestine
Mackenzie, B., & Garrick, M. D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00363.2005 · Cited by 213
Self-citationUeber degenerative Atrophie der spinalen Hinterstränge
Friedreich, N. (1863) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01878006 · Cited by 211
AINSWORTH, S. K., & KARNOVSKY, M. J. (1972) · Journal of Histochemistry & Cytochemistry · doi:10.1177/20.3.225 · Cited by 199 · cited 2×
“The grids were floated for 45 min on drops of a bismuth subnitrate-sodium tartrate solution as described by Ainsworth and Karnovsky (27) to enhance the electron opacity of ferritin.”
BackgroundMethodThe Cardiomyopathy of Friedreich's Ataxia Morphological Observations in 3 Cases
Lamarche, J. B., Côté, M., & Lemieux, B. (1980) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100022927 · Cited by 189 · cited 3×
“Two reports (2,3) contributed findings that are particularly relevant to current interpretations of FRDA cardiomyopathy: A substantial degree of inflammation (2); and the perinuclear accumulation of iron (3).”
BackgroundSelf-citationMitochondrial Ferritin: A New Player in Iron Metabolism
Drysdale, J., Arosio, P., Invernizzi, R., Cazzola, M., Volz, A., Corsi, B., Biasiotto, G., & Levi, S. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0577 · Cited by 180 · cited 1×
“The distribution of this protein in normal mammalian tissues is very restricted, and even mitochondria-rich tissues do not express its mRNA (41).”
BackgroundRegulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages
Liu, X.-B., Nguyen, N.-B. H., Marquess, K. D., Yang, F., & Haile, D. J. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2005.04.006 · Cited by 180
Ueber degenerative Atrophie der spinalen Hinterstränge
Friedreich, N. (1863) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01930976 · Cited by 168
Brain Hemosiderin and Superficial Siderosis of the Central Nervous System
Koeppen, A. H., & Dentinger, M. P. (1988) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198805000-00005 · Cited by 164 · cited 4×
“Mitochondrial ferritin (mouse polyclonal) Paraffin (4 mm) Chelation (25) and trypsin digestion Drs Paolo Santambrogio and Sonia Levi (Milan, Italy) (12) Ferroportin (rabbit polyclonal anti-ferroportin-specific peptide) Paraffin (4 mm) Chelation (25) and trypsin digestion Knutson et al.”
BackgroundMethodInfluentialSelf-citationMims, M. P., & Prchal, J. T. (2005) · Hematology · doi:10.1080/10245330500093419 · Cited by 123
Hemochromatosis and Hemosiderosis
MacDonald, R. A. (1963) · Kanzo · doi:10.2957/kanzo.5.34 · Cited by 121
Ferritin and Ferruginous Micelles in Normal Erythroblasts and Hypochromic Hypersideremic Anemias
BESSIS, M. C., & BRETON-GORIUS, J. (1959) · Blood · doi:10.1182/blood.v14.4.423.423 · Cited by 119
A physiological model to study iron recycling in macrophages
Delaby, C., Pilard, N., Hetet, G., Driss, F., Grandchamp, B., Beaumont, C., & Canonne-Hergaux, F. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.002 · Cited by 103
Isnard, R., Kalotka, H., Dürr, A., Cossée, M., Schmitt, M., Pousset, F., Thomas, D., Brice, A., Koenig, M., & Komajda, M. (1997) · Circulation · doi:10.1161/01.cir.95.9.2247 · Cited by 91 · cited 1×
“(6) correlated several quantitative echocardiographic findings with GAA trinucleotide expansions in 44 patients with FRDA.”
BackgroundRoth, J. A., Horbinski, C., Feng, L., Dolan, K. G., Higgins, D., & Garrick, M. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07595.2000 · Cited by 90
Self-citationMyocarditis in Friedreich's ataxia
Russell, D. S. (1946) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700580414 · Cited by 72 · cited 1×
“Two reports (2,3) contributed findings that are particularly relevant to current interpretations of FRDA cardiomyopathy: A substantial degree of inflammation (2); and the perinuclear accumulation of iron (3).”
BackgroundWardrop, S. L., & Richardson, D. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01752.x · Cited by 65
Ultrastructural Pathology of the Heart in Patients with ß-Thalassaemia Major
Kyriacou, K. C., Michaelides, Y., Senkus, R. J., Simamonian, K., Pavlides, N., Antoniades, L., & Zambartas, C. (2000) · Ultrastructural Pathology · doi:10.1080/01913120050118549 · Cited by 54
CLINICAL AND GENETIC ABNORMALITIES IN PATIENTS WITH FRIEDREICH'S ATAXIA
Ossee, M. I. C., Gid, V. A., Ampuzano, V. I. C., et al. (1996) · Cited by 44
Morphologic and functional characteristics of the heart in Friedreich's Ataxia
Unverferth, D. V., Schmidt, W. R., Baker, P. B., & Wooley, C. F. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90369-x · Cited by 43
Ferene-S as the chromogen for serum iron determinations
Eskelinen, S., Haikonen, M., & Räisänen, S. (1983) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518309168286 · Cited by 42
Fatal "Iron Heart" in an Adolescent: Biochemical and Ultrastructural Aspects of the Heart
Sanyal, S. K., Johnson, W. W., Jayalakshmamma, B., & Green, A. A. (1975) · PEDIATRICS · doi:10.1542/peds.55.3.336 · Cited by 33
Invernizzi, R., Cazzola, M., De Fazio, P., Rosti, V., Ruggeri, G., & Arosio, P. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb06379.x · Cited by 27 · cited 1×
“In sideroblastic anemia, erythroblasts show iron-positive cytoplasmic inclusions (ring sideroblasts) that react with anti-mitochondrial ferritin (12) but not with monoclonal antibodies to the H- or L- subunits of cytosolic ferritin (42).”
BackgroundTin-Protoporphyrin Prevents Experimental Superficial Siderosis in Rabbits
Koeppen, A. H., & Dickson, A. C. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.8.689 · Cited by 27 · cited 2×
“The initial steps were as described for vibratome sections (24).”
BackgroundSelf-citationFerene-S as the chromogen for serum iron determinations
Eskelinen, S., Haikonen, M., & Räisänen, S. (1983) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518309168286 · Cited by 27
A modified ferrozine method for the measurement of enzyme-bound iron
Davis, M. D., Kaufman, S., & Milstien, S. (1986) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(86)90006-0 · Cited by 25
Endomyocardial biopsy: A review of the literature
Przybojewski, J. Z. (1985) · Catheterization and Cardiovascular Diagnosis · doi:10.1002/ccd.1810110310 · Cited by 23 · cited 1×
“A comprehensive review of endocardial biopsies did not include patients with previously undiagnosed FRDA (45).”
BackgroundKESCHNER, H. W. (1951) · Southern Medical Journal · doi:10.1097/00007611-195110000-00011 · Cited by 23
Wardrop, S. L., Wells, C. A., Ravasi, T., Hume, D. A., & Richardson, D. R. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.99 · Cited by 19
Ultrastructural features of bone marrow cells from patients with acquired sideroblastic anemia
Djaldetti, M., Bergman, M., Salman, H., Cohen, A. M., & Bessler, H. (2004) · Microscopy Research and Technique · doi:10.1002/jemt.20024 · Cited by 9
PCTH: A Novel Orally Active Chelator for the Treatment of Iron Overload Disease
Lovejoy, D. B., Kalinowski, D. S., Bernhardt, P. V., & Richardson, D. R. (2006) · Hemoglobin · doi:10.1080/03630260500455367 · Cited by 9 · cited 1×
“If chelators are to be used, they must be able to enter the mitochondrial interior (48), and the combined administration of a chelating drug, an anti-inflammatory medication, and idebenone (49) may be beneficial.”
BackgroundNicolas, G., Jb, B., Delajartre, A. Y., Jf, G., & Horeau, J. (1971) · PubMed · Cited by 8
Transn1ission electron microscopy and immunolabelling for light and electron microscopy
Martins‐Green, M. M. (1990) · Oxford University Press eBooks · doi:10.1093/oso/9780199630882.003.0008 · Cited by 2
Research works printed but not linked: 2
- Ruggeri, G. and Iacobello, C. and Albertini, A. and (1984) Studies of human isoferritins in tissues and body fluids.. In Ferritins and isoferritins as biochemical markers. ( pp. 67 - 78 ). Amsterdam; New York : Elsevier.
- Nicolas, G. and Bouhour, J. B. and Delajartre, A. and (1971) Myocardiopathie secondaire à l'hémochromatose idiopathique. Arch Mal Coeur Vaiss, 64, pp. 1533 - 46.
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“As well as the neurodegeneration and measurable iron deposition, clinical symptoms include cardiac hypertrophy [1012] and (pre-)diabetes [1013], consistent with the general thesis described here that all are in part manifestations of iron dysregulation, and in which suitable chelation may be beneficial [1014; 1015] (b…”
BackgroundFriedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Koeppen, A. H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.01.010 · Cited by 447
“Some of the observations are at variance with the analysis of iron-handling proteins in the hearts of patients with FRDA [56].”
BackgroundResultInfluentialSelf-citationIron–sulfur cluster biogenesis and human disease
Rouault, T. A., & Tong, W. H. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.05.008 · Cited by 385
“observed in the hearts and brains of FRDA patients [ 35 ] (Box 1) and heart-specific knockout mouse models [36].”
BackgroundMitochondria as a Therapeutic Target in Heart Failure
Bayeva, M., Gheorghiade, M., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 332
Arosio, P., & Levi, S. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.02.005 · Cited by 321
“ferritin-loaded mitochondria [120].”
Metadata
- Authors
- Michael, S., Petrocine, S. V., Qian, J., Lamarche, J. B., Knutson, M. D., Garrick, M. D., & Koeppen, A. H.
- Affiliations
- Veterans Health Administration (US)
- Albany Medical College (US)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- University of Florida (US)
- University at Buffalo, State University of New York (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Koeppen, Arnulf H.
- Venue
- The Cerebellum
- Published
- 2006-12
- Volume
- 5
- Issue
- 4
- Pages
- 257-267
- ISSN
- 1473-4222 (ISSN-L)
- OpenAlex
- W2149278525
- Cited by
- 122
- References
- 52
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 9 · 2012: 13
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Cerebellum (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (R01DLK59794)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 065064, K01DK065064)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- Friedreich's ataxia, hypertrophic cardiomyopathy, frataxin deficiency, iron accumulation, ferritin, mitochondrial ferritin, DMT1, ferroportin, iron-responsive element, myocarditis, muscle fiber necrosis, bismuth subnitrate, mitochondrial damage
- MeSH terms
- Adult, Autopsy, Cardiomyopathy, Hypertrophic, Enzyme-Linked Immunosorbent Assay, Female, Ferritins, Friedreich Ataxia, Humans, Iron, Male, Middle Aged, Myocardium, Retrospective Studies, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.